首页> 美国政府科技报告 >Approach to Using Toxicogenomic Data in U.S. EPA Human Health Risk Assessments: A Dibutyl Phthalate Case Study
【24h】

Approach to Using Toxicogenomic Data in U.S. EPA Human Health Risk Assessments: A Dibutyl Phthalate Case Study

机译:在美国Epa人类健康风险评估中使用毒理基因组数据的方法:邻苯二甲酸二丁酯案例研究

获取原文

摘要

We developed a systematic approach for evaluating and utilizing toxicogenomic data in health assessment. This report describes this approach and a case study conducted for dibutyl phthalate (DBP) to illustrate the approach. As a result of the case-study exercise, we refined the initial case-study approach for general use in new chemical assessments. In this report, we reviewed some of the recent and ongoing activities regarding the use of genomic data in risk assessment, inside and outside of the U.S. Environmental Protection Agency (EPA). We also identified research needs, recommendations, and issues for future consideration when using genomic data in risk assessments. Toxicogenomics is the application of genomic technologies (e.g., transcriptomics, proteomics, metabolomics, genome sequence analysis) to study the effects of environmental chemicals on human health and the environment.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号